Ivacaftor 10 mg | 98.00%
TargetMol
Ivacaftor (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively.
More Information Supplier PageIvacaftor
Search Results
Cabozantinib 5 mg | 99.59%
TargetMol
Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50s: 0.035, 1.3, 4.6, 7 and 11.3 nM).
More Information Supplier PageCabozantinib
Spebrutinib 10 mg | 97.14%
TargetMol
Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
More Information Supplier PageSpebrutinib
Spebrutinib 50 mg | 97.14%
TargetMol
Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
More Information Supplier PageSpebrutinib
Spebrutinib 5 mg | 97.14%
TargetMol
Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
More Information Supplier PageSpebrutinib
PIK-93 25 mg | 99.83%
TargetMol
PIK-93 is the first potent, synthetic PI4K inhibitor with IC50 of 19 nM; inhibits PI3Kα with IC50 of 39 nM.
More Information Supplier PagePIK-93
PIK-93 10 mg | 99.83%
TargetMol
PIK-93 is the first potent, synthetic PI4K inhibitor with IC50 of 19 nM; inhibits PI3Kα with IC50 of 39 nM.
More Information Supplier PagePIK-93
CEP-28122 5 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
CEP-28122 2 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
CEP-28122 25 mg | Purity Not Available
TargetMol
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
More Information Supplier PageCEP-28122
